SCHEMBL19979595

SCHEMBL19979595

CCCCCCCCN(CP(=O)(OCCCC)OCCCC)CP(=O)(OCCCC)OCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.47
LPAR3 Q9UBY5 7/20 0.46
LPAR2 Q9HBW0 5/20 0.46
LPAR1 Q92633 2/20 0.46
LMNA P02545 1/20 0.38
ESR1 P03372 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CDC25A P30304 1/20 0.38
AGTR1 P30556 1/20 0.38
AKT1 P31749 1/20 0.38
ADRA1A P35348 1/20 0.38
KCNH2 Q12809 1/20 0.38
TSHR P16473 1/20 0.37
S1PR2 O95136 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37
S1PR5 Q9H228 1/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19979608 0.91 LPAR3 (0.46) CYP3A4LPAR3LPAR2LPAR1S1PR2
SCHEMBL19979609 0.87 CYP3A4 (0.39) CYP3A4LPAR3LPAR2LPAR1LMNA
SCHEMBL14770373 0.86 LPAR3 (0.47) CYP3A4LPAR3LPAR2LPAR1LMNA
SCHEMBL19979598 0.86 CYP3A4 (0.44) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL19979590 0.86 CYP3A4 (0.44) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL20049675 0.84 LPAR3 (0.42) CYP3A4LPAR3LPAR2LPAR1LMNA
SCHEMBL19979597 0.84 CYP3A4 (0.45) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL14778154 0.82 CYP3A4 (0.52) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL14740737 0.80 LPAR3 (0.46) LPAR3LPAR2LPAR1ESR1TSHR
SCHEMBL16238472 0.80 LPAR3 (0.42) CYP3A4LPAR3LPAR2LPAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10414784-B2 Aminobisphosphonate antiwear additives AFTON CHEMICAL CORPORATION (US) 2019-09-17 US disclosed
US-20180099985-A1 Novel AminoBisPhosphonate Antiwear Additives AFTON CHEMICAL CORP (US) 2018-04-12 US disclosed
US-20180099985-A1 Novel AminoBisPhosphonate Antiwear Additives AFTON CHEMICAL CORP (US) 2018-04-12 US disclosed
WO-2018053407-A1 NOVEL AMINOBISPHOSPHONATE ANTIWEAR ADDITIVES AFTON CHEMICAL CORPORATION (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180099985-A1 Novel AminoBisPhosphonate Antiwear Additives SOST, PSPH, FIBP CYP3A4 4743/4885LPAR3 1425/4885LPAR2 2993/4885
US-10414784-B2 Aminobisphosphonate antiwear additives SOST, AASDHPPT, SLC35B2 CYP3A4 4608/4885LPAR3 1673/4885LPAR2 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.